210 related articles for article (PubMed ID: 17261033)
21. Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen.
Osborne MR; Hewer A; Hardcastle IR; Carmichael PL; Phillips DH
Cancer Res; 1996 Jan; 56(1):66-71. PubMed ID: 8548777
[TBL] [Abstract][Full Text] [Related]
22. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans.
Beland FA; Churchwell MI; Doerge DR; Parkin DR; Malejka-Giganti D; Hewer A; Phillips DH; Carmichael PL; Gamboa da Costa G; Marques MM
J Natl Cancer Inst; 2004 Jul; 96(14):1099-104. PubMed ID: 15265972
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of lower genotoxicity of toremifene compared with tamoxifen.
Shibutani S; Ravindernath A; Terashima I; Suzuki N; Laxmi YR; Kanno Y; Suzuki M; Apak TI; Sheng JJ; Duffel MW
Cancer Res; 2001 May; 61(10):3925-31. PubMed ID: 11358807
[TBL] [Abstract][Full Text] [Related]
24. Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen.
Shibutani S; Suzuki N; Laxmi YR; Schild LJ; Divi RL; Grollman AP; Poirier MC
Cancer Res; 2003 Aug; 63(15):4402-6. PubMed ID: 12907611
[TBL] [Abstract][Full Text] [Related]
25. Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen.
Dasaradhi L; Shibutani S
Chem Res Toxicol; 1997 Feb; 10(2):189-96. PubMed ID: 9049430
[TBL] [Abstract][Full Text] [Related]
26. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and quantification of DNA adducts of 4,4'-methylenedianiline.
Schütze D; Sagelsdorff P; Sepai O; Sabbioni G
Chem Res Toxicol; 1996; 9(7):1103-12. PubMed ID: 8902264
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction.
Davis W; Hewer A; Rajkowski KM; Meinl W; Glatt H; Phillips DH
Cancer Res; 2000 Jun; 60(11):2887-91. PubMed ID: 10850433
[TBL] [Abstract][Full Text] [Related]
30. Activation of the tamoxifen derivative metabolite E to form DNA adducts: comparison with the adducts formed by microsomal activation of tamoxifen.
Pongracz K; Pathak DN; Nakamura T; Burlingame AL; Bodell WJ
Cancer Res; 1995 Jul; 55(14):3012-5. PubMed ID: 7606720
[TBL] [Abstract][Full Text] [Related]
31. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
32. Differential induction of N(2),3-ethenoguanine in rat brain and liver after exposure to vinyl chloride.
Morinello EJ; Koc H; Ranasinghe A; Swenberg JA
Cancer Res; 2002 Sep; 62(18):5183-8. PubMed ID: 12234982
[TBL] [Abstract][Full Text] [Related]
33. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
Fan PW; Zhang F; Bolton JL
Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
[TBL] [Abstract][Full Text] [Related]
34. Formation, persistence, and identification of DNA adducts formed by the carcinogenic environmental pollutant o-anisidine in rats.
Naiman K; Dracínský M; Hodek P; Martínková M; Schmeiser HH; Frei E; Stiborová M
Toxicol Sci; 2012 Jun; 127(2):348-59. PubMed ID: 22403159
[TBL] [Abstract][Full Text] [Related]
35. Correlation of tumors with DNA adducts from methyl eugenol and tamoxifen in rats.
Waddell WJ; Crooks NH; Carmichael PL
Toxicol Sci; 2004 May; 79(1):38-40. PubMed ID: 14976343
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the major DNA adduct formed by alpha-hydroxy-N-desmethyltamoxifen in vitro and in vivo.
Gamboa da Costa G; Hamilton LP; Beland FA; Marques MM
Chem Res Toxicol; 2000 Mar; 13(3):200-7. PubMed ID: 10725117
[TBL] [Abstract][Full Text] [Related]
37. Analysis of tamoxifen-DNA adducts in endometrial explants by MS and 32P-postlabeling.
Beland FA; Churchwell MI; Hewer A; Phillips DH; Gamboa da Costa G; Marques MM
Biochem Biophys Res Commun; 2004 Jul; 320(2):297-302. PubMed ID: 15219826
[TBL] [Abstract][Full Text] [Related]
38. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro.
Hemminki K; Widlak P; Hou SM
Carcinogenesis; 1995 Jul; 16(7):1661-4. PubMed ID: 7614704
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
Randerath K; Moorthy B; Mabon N; Sriram P
Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
[TBL] [Abstract][Full Text] [Related]
40. DNA adduct formation by tamoxifen and structurally-related compounds in rat liver.
Rajaniemi H; Mäntylä E; Hemminki K
Chem Biol Interact; 1998 May; 113(2):145-59. PubMed ID: 9717515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
